MBrace Therapeutics

About:

MBrace Therapeutics is a privately held biopharmaceutical business.

Top Investors: TPG, Venrock, Alta Partners, Avidity Partners, Cowen Healthcare Investments

Description:

MBrace Therapeutics is a privately held biopharmaceutical business dedicated to improving cancer patients' quality of life by developing antibody-drug conjugates (ADCs) against novel oncology targets.

Total Funding Amount:

$110M

Headquarters Location:

San Diego, California, United States

Founded Date:

2019-01-01

Founders:

Isan Chen, Renata Pasqualini, Wadih Arap

Number of Employees:

11-50

Last Funding Date:

2023-11-14

IPO Status:

Private

Industries: